4-BCOX,
4-benzyl-3-crotonyl-2-oxazolidinone,
133812-16-5,
Locostatin,
(S)-4-Benzyl-3-(but-2-enoyl)oxazolidin-2-one,
(S,E)-4-BENZYL-3-(BUT-2-ENOYL)OXAZOLIDIN-2-ONE,
(4S)-N-Crotonyl-4-benzyl-2-oxazolidinone,
UIC-1005,
(N-Crotonyl)-(4S)-benzyl-2-oxazolidinone,
(4S)-3-[(E)-But-2-enoyl]-4-benzyl-2-oxazolidinone,
90719-30-5,
(S,E)-4-benzyl-3-but-2-enoyloxazolidin-2-one,
(4S)-4-benzyl-3-[(E)-but-2-enoyl]-1,3-oxazolidin-2-one,
Cell Sheet Migration Inhibitor, Locostatin,
AC1NWBM0,
SCHEMBL5058893,
SCHEMBL5058895,
Locostatin, >=98% (HPLC),
UTZAFVPPWUIPBH-QSLRECBCSA-N,
ZINC2562269,
6126AA,
BS0264,
MFCD00278769,
AKOS015913245,
3-Crotonyl-4beta-benzyloxazolidine-2-one,
AJ-40727,
AK103728,
AS-41290,
SC-68496,
AB0047575,
AX8235267,
ST24036183,
(S)-(+)-4-Benzyl-3-crotonyl-2-oxazolidinone,
3-(2-Butenoyl)-4beta-benzyloxazolidine-2-one,
X-3720,
(s)-3-((e)-but-2-enoyl)-4-benzyloxazolidinone,
(4S)-3-((E)-2-butenoyl)-4-benzyl-2-oxazolidinone,
(S)-(+)-4-Benzyl-3-crotonyl-2-oxazolidinone, 97%,
I14-45647,
(S,E)-4-benzyl-3-(but-2-enoyl)oxazolidin-2-one, 98%,
(4S)-3-[(E)-1-Oxo-2-butenyl]-4-(phenylmethyl)-2-oxazolidinone,
4-Bcox,
C14H15NO3,
4-Benzyl-3-crotonyl-2-oxazolidinone,
CID5702600,
A16079,
C529490,
(N-CROTONYL)-(4S)-ISOPROPYL-2-OXAZOLIDINONE,